Literature DB >> 1303173

Both mutations in G6PD A- are necessary to produce the G6PD deficient phenotype.

M Town1, J M Bautista, P J Mason, L Luzzatto.   

Abstract

The high prevalence of glucose 6-phosphate dehydrogenase (G6PD) deficiency in African populations is due almost entirely to the enzyme variant A-, which differs from the wild-type G6PD B by two amino acid replacements, 68 Val-->Met and 126 Asn-->Asp. The non-deficient polymorphic variant G6PD A contains only the mutation 126 Asn-->Asp. The frequencies of the G6PD A and of the G6PD A- genes in parts of Africa are both about 0.2. The 68 Val-->Met mutation has not been found in a B background. This could be because the 68 Val-->Met mutation happened to arise in an A gene in the first instance, or because the 68 Val-->Met mutation alone is not sufficient to cause G6PD deficiency. We have approached this question by producing G6PD B, A, A-, and G6PD 68 Val-->Met in a bacterial expression system and analysing their biochemical properties. With each single mutation we found a slight decrease in both the specific activity and the yield of enzyme when compared to G6PD B. When both mutations were introduced together, there was a roughly additive effect on specific activity, but a much more drastic effect on enzyme yield (4% of normal). This synergistic effect was also demonstrated on thermal stability, especially at low NADP concentrations. Comparable results were produced when the replacement 119 Gln-->Glu was studied instead of 126 Asn-->Asp. We infer that the coexistence of the two mutations is responsible for enzyme deficiency in G6PD A- because they act synergistically in causing instability of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1303173     DOI: 10.1093/hmg/1.3.171

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  19 in total

1.  Complex signatures of natural selection at the Duffy blood group locus.

Authors:  Martha T Hamblin; Emma E Thompson; Anna Di Rienzo
Journal:  Am J Hum Genet       Date:  2001-12-20       Impact factor: 11.025

Review 2.  About hemoglobins, G6PD and parasites in red cells.

Authors:  L Luzzatto
Journal:  Experientia       Date:  1995-03-15

Review 3.  Clinically relevant genetic variations in drug metabolizing enzymes.

Authors:  Navin Pinto; M Eileen Dolan
Journal:  Curr Drug Metab       Date:  2011-06       Impact factor: 3.731

4.  Evidence for balancing selection from nucleotide sequence analyses of human G6PD.

Authors:  Brian C Verrelli; John H McDonald; George Argyropoulos; Giovanni Destro-Bisol; Alain Froment; Anthi Drousiotou; Gerard Lefranc; Ahmed N Helal; Jacques Loiselet; Sarah A Tishkoff
Journal:  Am J Hum Genet       Date:  2002-10-11       Impact factor: 11.025

5.  Marked variation in prevalence of malaria-protective human genetic polymorphisms across Uganda.

Authors:  Andrew Walakira; Stephen Tukwasibwe; Moses Kiggundu; Federica Verra; Patrick Kakeeto; Emmanuel Ruhamyankaka; Chris Drakeley; Grant Dorsey; Moses R Kamya; Samuel L Nsobya; Philip J Rosenthal
Journal:  Infect Genet Evol       Date:  2017-09-19       Impact factor: 3.342

6.  A novel G6PD mutation leading to chronic hemolytic anemia.

Authors:  Jenny McDade; Tatiana Abramova; Nicole Mortier; Thad Howard; Russell E Ware
Journal:  Pediatr Blood Cancer       Date:  2008-12       Impact factor: 3.167

7.  A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala-->Gly), is the major polymorphic variant in tribal populations in India.

Authors:  J S Kaeda; G P Chhotray; M R Ranjit; J M Bautista; P H Reddy; D Stevens; J M Naidu; R P Britt; T J Vulliamy; L Luzzatto
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

8.  PCR-based allelic discrimination for glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ugandan umbilical cord blood.

Authors:  Jennifer Hsu; Deanna Fink; Erica Langer; Michelle L Carter; Derrik Bengo; Susan Ndidde; Tina Slusher; Julie A Ross; Troy C Lund
Journal:  Pediatr Hematol Oncol       Date:  2013-12-05       Impact factor: 1.969

9.  Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.

Authors:  Mathula Thangarajh; Genyan Yang; Dana Fuchs; Maria R Ponisio; Robert C McKinstry; Alok Jaju; Michael J Noetzel; James F Casella; Emily Barron-Casella; W Craig Hooper; Sheree L Boulet; Christopher J Bean; Meredith E Pyle; Amanda B Payne; Jennifer Driggers; Heidi A Trau; Bruce A Vendt; Mark Rodeghier; Michael R DeBaun
Journal:  Br J Haematol       Date:  2012-09-07       Impact factor: 6.998

10.  Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.

Authors:  Marla K Johnson; Tamara D Clark; Denise Njama-Meya; Philip J Rosenthal; Sunil Parikh
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.